Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals

Journal of Neuroimmunology

Volumn 97, Issue 1-2, 1999, Pages 163-171

  Lombardi, V R M ^a   Garcia M ^a   Rey, L ^a   Cacabelos, R ^a  

^a Centro de Investigacion Biomedica EuroEspes   (Spain)

Author keywords

Apoptosis; Elderly; IL 1 ; IL 10; IL 6; T cell subsets; TNF

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CYTOKINE; FAS ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALZHEIMER DISEASE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; HYPERTHERMIA; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADP-RIBOSYL CYCLASE; AGED; ALZHEIMER DISEASE; ANTIGENS, CD; ANTIGENS, CD26; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD38; ANTIGENS, CD4; ANTIGENS, CD56; ANTIGENS, CD7; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CELL DIVISION; CYTOKINES; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; LYMPHOCYTE SUBSETS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NAD+ NUCLEOSIDASE; PHYTOHEMAGGLUTININS; RECEPTORS, INTERLEUKIN-2; THYMIDINE; TRITIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032964511     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00046-6     Document Type: Article

References (49)

1. Adler W.H., Baskar P.V., Chrest F.J., Dorsey Cooper B., Winchurch R.A., Nagel J.E. HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient. Mech. Ageing Devel. 96:1997;137-155.
2. Albright J.W., Albright J.F. Impaired natural killer cell function as a consequence of aging. Exp. Gerontol. 33:1998;13-25.
3. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders. 3rd edn. Revised. DSM-III-R. Washington, DC.
4. Arai K., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:1990;783-836.
5. Baloh R.W., Vinters H.V. White matter lesions and disequilibrium in older people: II. Clinicopathologic correlation. Arch. Neurol. 52:1995;975-981.
6. Banker D.E., Groudine M., Wilman C.L., Norwood T., Appelbaum F.R. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents. Leukemia Res. 22:1998;221-239.
7. Blumenthal H.T. Fidelity assurance mechanisms of the brain with special reference to its immunogenic CNS compartment: their role in aging and aging-associated neurological disease. J. Gerontol. A. Biol. Sci. Med. Sci. 52:1997;B1-9.
8. Burns E.A., Goodwin J.S. Immunodeficiency of aging. Drugs Aging. 11:1997;374-397.
9. Carson A.D., Ribeiro J.M. Apoptosis and disease. Lancet. 341:1993;1251-1254.
10. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., Pober J.S., Wick T.M., Konkle T.M., Schwartz B.S., Barnathan E.S., McCrae K.R., Hug B.A., Schmidt A.M., Stern D.M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 91:1998;3527-3561.
11. Cossarizza A., Ortolani C., Monti D., Franceschi C. Cytometric analysis of immunofluorescence. Cytometry. 27:1997;297-313.
12. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.C., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
13. Doria G., Biozzi G., Mouton D., Covelli V. Genetic control of immune responsiveness, aging and tumor incidence. Mech. Ageing Devel. 96:1997;1-13.
14. Effros R.B. Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly. Am. J. Hum. Genet. 62:1998;1003-1007.
15. Ershler W.B., Harman S.M., Keller E.T. Immunologic aspects of osteoporosis. Dev. Comp. Immunol. 21:1997;487-499.
16. Flaherty D.K., Wagner C.A., Gross G.J., Panyik M.A. Aging and lymphocyte subsets in the spleen and peripheral blood of Sprague-Dawley rat. Immunopharmacol. Immunotoxicol. 19:1997;185-195.
17. Folstein M.F., Folstein S.E., McHug P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
18. Gasiorowski K., Leszek J. A proposed new strategy of immunotherapy for Alzheimer's disease. Med. Hypotheses. 49:1997;319-326.
19. Glasova M., Konokova E., Stasakova J., Babusikova O. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells. Neoplasma. 45:1998;88-95.
20. Gold R. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71:1994;219-225.
21. Grubeck Loebenstein B. Changes in the aging immune system. Biologicals. 25:1997;205-208.
22. Henneberg A., Riedl B., Dumke H.O., Kornhuber H.H. T-lymphocyte subpopulations in schizophrenic patients. Eur. Arch. Psychiatr. Neurol. Sci. 239:1990;283-284.
23. Heslop H.E., Smith C.A., Roskrow M.A., Brenner M.K., Rooney C.M. Cellular immunotherapy of EBV-associated lymphomas. Hematol. Cell Ther. 40:1998;79-82.
24. Heuser M.D., Adler W.H. Immunological aspects of aging and malnutrition: consequences and intervention with nutritional immunomodulators. Clin. Geriatr. Med. 13:1997;697-715.
25. Hickey W.F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1:1991;97-105.
26. Hirokawa K. Reversing and restoring immune functions. Mech. Ageing Dev. 93:1997;119-124.
27. Hodes R.J. Aging and the immune system. Immunol. Rev. 160:1997;5-8.
28. Hopkins S.J., Rothwell N.J. Cytokines and the immune system: I. Expression and recognition. Trends Neurosci. 18:1995;83-88.
29. Horan M.A., Ashcroft G.S. Ageing, defence mechanisms and the immune system. Age Ageing. 26:1997;15-19.
30. Kanne S.M., Balota D.A., Storandt M., McKeel D.W., Morris J.C. Relating anatomy to function in Alzheimer's disease. Neurological profiles predict regional neuropathology 5 years later. Neurology. 50:1998;979-985.
31. Landay A.L., Jessop C., Lenette E.T., Levy J.A. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet. 338:1991;702-712.
32. Lombardi V.R.M., Cacabelos R. Apoptosis in neurodegenerative diseases: the neuroimmune network. Neurogeront. Neurogeriatr. 2:1998;105-124.
33. Maneiro E., Lombardi V.R.M., Cacabelos R. Neuroimmune dysfunction in Alzheimer's disease. Influence of β-amyloid, interleukin-1β, histamine and ApoE-related sera from patients with Alzheimer's disease on microglial cells. Neurogeront. Neurogeriatr. 2:1998;77-104.
34. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA work group. Neurology. 34:1984;939-944.
35. McNerlan S.E., Rea I.M., Alexander H.D., Morris T.C. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging. J. Clin. Immunol. 18:1998;31-38.
36. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
37. Meyaard L., Otto S.A., Jonker R.R., Mijnster M.J., Keet R.P.M., Miedema F. Programmed cell death of T cells in HIV-1 infection. Science. 257:1992;217-219.
38. Mooradian A. Effect of aging on the blood-brain barrier. Neurobiol. Aging. 9:1988;31-39.
39. Nerad J.L., Griffiths J.K., Van der Meer J.W., Endres S., Poutsiaka D.D., Keusch G.T., Bennish M., Salam M.A., Dinarello C.A., Cannon J.G. Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. J. Leukoc. Biol. 52:1992;687-692.
40. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128:1998;127-137.
41. Pawlec G., Adibzadeh M., Solana R., Beckman I. The T cell in the ageing individual. Mech. Ageing Devel. 93:1997;35-45.
42. Pei R., Wang G., Tarsitani C., Rojo S., Chen T., Takemura S., Liu A., Lee J. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum. Immunol. 59:1998;313-322.
43. Reisberg, B., Ferris, S.H., De Leon, M.J., 1985. Senile dementia of the Alzheimer type: diagnosis and differential diagnostic features with special reference to functional assessment staging. In: Traber, J., Gispan, W.H. (Eds.), Senile Dementia of the Alzheimer-Type. Springer, Berlin.
44. Thoman M.L. Effects of the aged microenvironment on CD4+ T cell maturation. Mech. Ageing Dev. 96:1997;75-88.
45. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;2239-2244.
46. Voets A.J., Tulner L.R., Ligthart G.J. Immunosenescence revisited. Does it have any clinical significance? Drugs Aging. 11:1997;1-6.
47. Wekerle H., Sun D., Oropeza-Wekerle R.L., Meyermann R. Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. J. Exp. Biol. 132:1987;43-57.
48. Wick G., Grubeck Loebenstein B. The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp. Gerontol. 32:1997;401-413.
49. Zheng B., Han S., Takahashi Y., Kelsoe G. Immunosenescence and germinal center reaction. Immunol. Rev. 160:1997;63-77.